These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 12019088)

  • 141. Potent in vivo antiviral activity of the herpes simplex virus primase-helicase inhibitor BAY 57-1293.
    Betz UA; Fischer R; Kleymann G; Hendrix M; Rübsamen-Waigmann H
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1766-72. PubMed ID: 12019088
    [TBL] [Abstract][Full Text] [Related]  

  • 142. Helicase primase: targeting the Achilles heel of herpes simplex viruses.
    Kleymann G
    Antivir Chem Chemother; 2004 May; 15(3):135-40. PubMed ID: 15266895
    [TBL] [Abstract][Full Text] [Related]  

  • 143. Pharmacokinetics-pharmacodynamics of the helicase-primase inhibitor pritelivir following treatment of wild-type or pritelivir-resistant virus infection in a murine herpes simplex virus 1 infection model.
    Biswas S; Sukla S; Goldner T; Field HJ; Kropeit D; Paulsen D; Welbers A; Ruebsamen-Schaeff H; Zimmermann H; Birkmann A
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3843-52. PubMed ID: 24752278
    [TBL] [Abstract][Full Text] [Related]  

  • 144. The helicase primase inhibitor, BAY 57-1293 shows potent therapeutic antiviral activity superior to famciclovir in BALB/c mice infected with herpes simplex virus type 1.
    Biswas S; Jennens L; Field HJ
    Antiviral Res; 2007 Jul; 75(1):30-5. PubMed ID: 17175035
    [TBL] [Abstract][Full Text] [Related]  

  • 145. Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease.
    Crute JJ; Grygon CA; Hargrave KD; Simoneau B; Faucher AM; Bolger G; Kibler P; Liuzzi M; Cordingley MG
    Nat Med; 2002 Apr; 8(4):386-91. PubMed ID: 11927945
    [TBL] [Abstract][Full Text] [Related]  

  • 146. New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease.
    Kleymann G; Fischer R; Betz UA; Hendrix M; Bender W; Schneider U; Handke G; Eckenberg P; Hewlett G; Pevzner V; Baumeister J; Weber O; Henninger K; Keldenich J; Jensen A; Kolb J; Bach U; Popp A; Mäben J; Frappa I; Haebich D; Lockhoff O; Rübsamen-Waigmann H
    Nat Med; 2002 Apr; 8(4):392-8. PubMed ID: 11927946
    [TBL] [Abstract][Full Text] [Related]  

  • 147. Intravenous infusion of cereport increases uptake and efficacy of acyclovir in herpes simplex virus-infected rat brains.
    Bidanset DJ; Placidi L; Rybak R; Palmer J; Sommadossi JP; Kern ER
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2316-23. PubMed ID: 11451691
    [TBL] [Abstract][Full Text] [Related]  

  • 148. Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections.
    Ormrod D; Scott LJ; Perry CM
    Drugs; 2000 Apr; 59(4):839-63. PubMed ID: 10804039
    [TBL] [Abstract][Full Text] [Related]  

  • 149. Effects of famciclovir and valacyclovir on herpes simplex virus type 1 infection, latency, and reactivation in mice: how dissimilar are study results?
    Thackray AM; Field HJ
    J Infect Dis; 2000 Apr; 181(4):1517-8. PubMed ID: 10762588
    [No Abstract]   [Full Text] [Related]  

  • 150. The impact of the herpetic eye disease studies on the management of herpes simplex virus ocular infections.
    Sudesh S; Laibson PR
    Curr Opin Ophthalmol; 1999 Aug; 10(4):230-3. PubMed ID: 10621528
    [TBL] [Abstract][Full Text] [Related]  

  • 151. The comparative effects of famciclovir and valacyclovir on herpes simplex virus type 1 infection, latency, and reactivation in mice.
    LeBlanc RA; Pesnicak L; Godleski M; Straus SE
    J Infect Dis; 1999 Sep; 180(3):594-9. PubMed ID: 10438344
    [TBL] [Abstract][Full Text] [Related]  

  • 152. Bypass of lethality with mosaic mice generated by Cre-loxP-mediated recombination.
    Betz UA; Vosshenrich CA; Rajewsky K; Müller W
    Curr Biol; 1996 Oct; 6(10):1307-16. PubMed ID: 8939573
    [TBL] [Abstract][Full Text] [Related]  

  • 153. Differential effects of famciclovir and valaciclovir on the pathogenesis of herpes simplex virus in a murine infection model including reactivation from latency.
    Thackray AM; Field HJ
    J Infect Dis; 1996 Feb; 173(2):291-9. PubMed ID: 8568288
    [TBL] [Abstract][Full Text] [Related]  

  • 154. Species differences in the disposition of acyclovir.
    de Miranda P; Krasny HC; Page DA; Elion GB
    Am J Med; 1982 Jul; 73(1A):31-5. PubMed ID: 7102710
    [TBL] [Abstract][Full Text] [Related]  

  • 155. A quantitative study of the effects of several nucleoside analogues on established herpes encephalitis in mice.
    Field HJ; Anderson JR; Efstathiou S
    J Gen Virol; 1984 Apr; 65 ( Pt 4)():707-19. PubMed ID: 6323620
    [TBL] [Abstract][Full Text] [Related]  

  • 156.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 157.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 158.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 159.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 160.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.